… PAUWELS … PAUWELS … I would like to acknowledge the dedicated individuals who
prepared the Workshop Report and the effective leadership of the Workshop Chair, Professor …

Chronic obstructive pulmonary disease is a leading cause of death and disability, but has
only recently been extensively explored from a cellular and molecular perspective. There is a …

Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity and
mortality and represents a substantial economic and social burden throughout the world. It is …

Background The Standards for the Diagnosis and Treatment of Patients with COPD
document 2004 updates the position papers on chronic obstructive pulmonary disease (COPD) …

… We thank II&la Azijn for excellent te~~n~~~l assistants, ~h~st~an~ CaIXebaut and Laurent
Palmacrts for fine editorial help and Dr, Chris Koelandts for mycopfasma testing R. Pauwels is …

… Pedersen S, Bateman E, Boushey H, Bousquet J, Busse W, Clark T, Pauwels R. Aiming for
guideline defined total control of asthma improves one-year asthma outcomes: results of the …

Background The role of long-acting, inhaled β 2 -agonists in treating asthma is uncertain. In
a double-blind study, we evaluated the effects of adding inhaled formoterol to both lower and …

Background Inhaled longacting β 2 agonists improve lung function and health status in
symptomatic chronic obstructive pulmonary disease (COPD), whereas inhaled corticosteroids …

Background and Methods Although patients with chronic obstructive pulmonary disease (COPD)
should stop smoking, some do not. In a double-blind, placebo-controlled study, we …

IN the search for compounds active against human immunodeficiency virus (HIV), we have
found that members of a novel series of tetrahydro-imidazo[4,5,1-jk][l,4]-benzodiazepin-2(1H)-…